New York, NY 19 Feb 2021: The global badminton shoes market size is expected to reach USD 5.51 billion by 2027 according to a new study by Polaris Market Research. The report “Badminton Shoes Market Share, Size, Trends, Industry Analysis Report, By Sole Type (Rubber Sole and Non Marking); By Demographics (Men, Women, Unisex, and Kids); By Buyer Type (Individual, Institutional, and Promotional), By Sales Channel (Independent Sports Outlet, Franchised Sports Outlet, Modern Trade Channels, Direct to Customer Channel, and Third Party Online Channel), By Regions; Segment Forecast, 2020 –2027”gives a detailed insight into current market dynamics and provides analysis on future market growth.
As the penetration of badminton has increased, more and more consumers prefer badminton footwear to be comfortable to have positive impact on their performance. These shoes typically possess cushioning effect to spread pressure on feet, to avoid any sort of injury during tournament. Earlier, badminton shoes were manufactured by weaving multiple layers of fabrics with each other causing heavy generation of waste as well as requiring more labor force. With product innovation, shoe-knitting is a technology that knits badminton shoes just like a pair of socks.
Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/badminton-shoes-market/request-for-sample
It has been a very primitive and effective strategy to promote products offered for a particular sport by collaborating with famous personalities of that game. This helps the consumers attach their feelings for famous sports player with the footwear and apparels brand they adorn. The manufacturers of badminton shoes have been collaborating with key badminton players from particular countries to endorse their products. This has aided in significant revenue rise with several badminton enthusiasts wearing specific shoes to play the sport.
As several badminton tournaments are being hosted around the world every year, the number of participants playing the tournaments have also increased considerably. As more and more local players have started to represent badminton on an international stage, viewership has also witnessed an abrupt increase. This, in turn, has augmented the demand for various badminton accessories including shoes.
Many badminton manufacturers have utilized outsourcing strategy efficiently in recent past to earn more profit margins. Outsourcing the production of badminton shoes to regions like Asia helps in reducing the cost price of the product effectively. The lower wages required to manufacture shoes is one of the key reasons for Asian countries becoming a shoes manufacturing hub.
To get Incredible Discounts on this Premium Report, Click At : https://www.polarismarketresearch.com/industry-analysis/badminton-shoes-market/request-for-discount-pricing
Market participants such as Li Ning Company Limited, Lotto Sport Italia, ASICS Corporation, Yonex Co., Ltd, Adidas AG, VICTOR RACKETS IND. CORP, Mizuno USA, Inc., Carlton Sports, Babolat, Cosco (India) Ltd, and Puma SE. are some of the key players operating in the global market.
Companies like Babolat, Li Ning, Yonex, Adidas, Puma and Asics have focused on offering their products in all geographical regions through various channels at company’s disposal. While companies like Lotto and Mizuno have been focusing majorly on regions like Europe, North America and Asia. Carlton Sports have been targeting United Kingdom and USA through their online channel SportsDirect and some countries of Asia through e-commerce websites. Victor Rackets Ind. Corp are focusing on countries like Taiwan and India. Cosco India has only focused on Indian market.
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: [email protected]
How about a well-assessed report on the Badminton Shoes market that provides insightful analysis of various trends/services/products which has the potential of bringing a paradigm shift in the growth rate?
Fact.MR is the answer to all your questions based on the ongoing developments in the Badminton Shoes market!
The report, with bull’s eye analysis, has the potential of forming the crux of the success of your organization with a focus on various parameters such as drivers, restraints, challenges, opportunities, and competitive landscape assessment.
It has caused an economic earthquake and has brought unprecedented losses.
As the world struggles to fight with the COVID-19 pandemic, policymakers, industry players, and investors in the Badminton Shoes market are trying to tackle the deadly pandemic of economic loss.
This has made them capable of sustaining their businesses.
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Worldwide sales of badminton shoes are estimated to surpass 53,400 thousand units in 2019, up from 50,782 thousand units in 2018, as per the latest report published by Fact.MR.
Surging popularity of racquet sports, with badminton being a prominent one, continues to be one of the key factors fuelling investments in badminton shoes market.
The pursuit of badminton as a fast and invigorating sport by people of varying athletic abilities is fostering the popularity of this sport over other types of racquet sports.
This ever-increasing enthusiasm for badminton is foreseen to boost sales of high-quality badminton accessories, including badminton shoes.Request to View Sample of Report @ https://www.factmr.com/connectus/sample?flag=S_id=754According to the report, customers will continue to show high inclination toward badminton shoes with rubber soles owing to higher degree of versatility and flexibility offered, with global sales estimated to surpass 38,800 thousand tons.
This, in turn, makes them a valuable target audience for companies operating in the badminton shoes market.
As per the Fact.MR study, East Asia will continue to be a highly lucrative market for badminton shoes, with sales estimated to surpass 32,400 thousand units in 2019.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
